Amarin Corp plc (AMRN) Misses Q1 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to Amarin Corp plc (AMRN) Misses Q1 EPS by 3c

Amarin Reports First Quarter 2016 Financial Results and Provides Update on Operations

May 5, 2016 7:03 AM EDT

BEDMINSTER, NJ and DUBLIN, IRELAND -- (Marketwired) -- 05/05/16 -- Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced financial results for the quarter ended March 31, 2016, and provided an update on company operations.

Key Amarin achievements since December 31, 2015 include:

Revenue growth: Recognized $25.3 million in net product revenue from Vascepa® sales in Q1 2016 compared to $15.6 million in Q1 2015, an increase of approximately 63%;... More